GLOBAL Leukemia in Children 0-14 Statistics 2018, Incidence and Mortality and Human Development Index (HDI): GLOBOCAN Sources and Methods.
GLOBAL Incidence
Human Development Index
Leukemia
children
mortality
Journal
Asian Pacific journal of cancer prevention : APJCP
ISSN: 2476-762X
Titre abrégé: Asian Pac J Cancer Prev
Pays: Thailand
ID NLM: 101130625
Informations de publication
Date de publication:
01 May 2020
01 May 2020
Historique:
received:
13
01
2020
entrez:
28
5
2020
pubmed:
28
5
2020
medline:
3
2
2021
Statut:
epublish
Résumé
Cancer is the second leading cause of death in children under 15 and leukemia is the most common type of cancer in this age group. The aim of the present study is to investigate the incidence and mortality of leukemia in children aged 0-14 years and its relationship with Human Development Index (HDI in different countries of the world. Methods: Incidence and mortality rates were obtained from GLOBOCAN and Country's income from World Bank. The data analysis was conducted using correlation analysis. The association of incidence and mortality rates with HDI was investigated using linear regression models. The results revealed a significant positive correlation between the incidence rate and Gross National Income per capita (r = 0.464, P <0.0001), mean years of schooling (r = 0.566, P <0.0001), life expectancy at birth (r = 0.712, P <0.0001) and expected years of schooling (r = 0.604, P <0.0001). The results also demonstrated a positive and significant correlation between mortality rate and life expectancy at birth (r = 0.199, P <0.0001). An improvement in HDI [Beta = 7.7, CI95% (0.1, 15.3)] and life Expectancy at birth [Beta = 0.1, CI95% (0.03, 0.1)] caused a significantly rise in the incidence of leukemia. Moreover, the improved HDI [Beta = 6.2, CI95% (1.9, 10.5)] was associated with increased mean years of schooling [Beta = -0.1, CI95% (-0.2, -0.01)] and expected years of schooling [Beta = -0.1, CI95% (-0.3, -0.08). As the HDI increases, incidence and mortality from of leukemia increases indicating a change in factors that affects leukemia incidences.
Identifiants
pubmed: 32458660
doi: 10.31557/APJCP.2020.21.5.1487
pmc: PMC7541866
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1487-1494Références
Eur J Cancer. 2012 Apr;48(6):889-95
pubmed: 21795040
Epidemiol Serv Saude. 2018 Sep 21;27(3):e2017310
pubmed: 30281713
Int J Cancer. 2015 Mar 1;136(5):E359-86
pubmed: 25220842
Pediatr Blood Cancer. 2004 Dec;43(7):749-57
pubmed: 15390289
CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49
pubmed: 19474385
Cancer. 2008 Jan 15;112(2):416-32
pubmed: 18074355
Int J Cancer. 2010 Dec 15;127(12):2893-917
pubmed: 21351269
Pediatr Blood Cancer. 2009 Jul;53(1):13-6
pubmed: 19260104
Br J Cancer. 2010 Feb 2;102(3):620-6
pubmed: 20051948
Br J Haematol. 2007 Dec;139(5):809-19
pubmed: 17941952
Sci Total Environ. 2015 Sep 1;526:153-76
pubmed: 25955692
J Pediatr Gastroenterol Nutr. 2006 May;42(5):568-72
pubmed: 16707982
J Pediatr Hematol Oncol. 2011 Oct;33(7):506-15
pubmed: 21941143
Cancer Res Treat. 2016 Jul;48(3):869-82
pubmed: 26790965
Cad Saude Publica. 2009 Sep;25(9):1875-82
pubmed: 19750375
Lancet Oncol. 2017 Jun;18(6):719-731
pubmed: 28410997
Arch Dis Child. 2007 Oct;92(10):890-7
pubmed: 17566053
Chem Biol Interact. 2012 Apr 5;196(3):59-67
pubmed: 22326931
CA Cancer J Clin. 2012 Jul-Aug;62(4):220-41
pubmed: 22700443
Blood. 2010 Nov 11;116(19):3724-34
pubmed: 20664057
Leuk Res. 2015 Apr;39(4):429-34
pubmed: 25703352
Lancet Haematol. 2018 Jan;5(1):e14-e24
pubmed: 29304322
Eur J Cancer. 2004 Jun;40(9):1351-60
pubmed: 15177495
Cancer Causes Control. 2009 Nov;20(9):1671-80
pubmed: 19672681
Br J Ind Med. 1986 Oct;43(10):685-91
pubmed: 3465366